4.24
price up icon6.80%   0.27
after-market アフターアワーズ: 4.19 -0.05 -1.18%
loading
前日終値:
$3.97
開ける:
$3.97
24時間の取引高:
2.90M
Relative Volume:
2.64
時価総額:
$195.51M
収益:
$82.71M
当期純損益:
$-102.24M
株価収益率:
-1.1553
EPS:
-3.67
ネットキャッシュフロー:
$-76.57M
1週間 パフォーマンス:
+1.19%
1か月 パフォーマンス:
-60.59%
6か月 パフォーマンス:
-66.61%
1年 パフォーマンス:
-68.71%
1日の値動き範囲:
Value
$3.605
$4.24
1週間の範囲:
Value
$3.605
$4.25
52週間の値動き範囲:
Value
$3.42
$20.70

Urogen Pharma Ltd Stock (URGN) Company Profile

Name
名前
Urogen Pharma Ltd
Name
セクター
Healthcare (1170)
Name
電話
972 9 770 7601
Name
住所
9 HA'TA'ASIYA ST, RA'ANANA
Name
職員
234
Name
Twitter
@UroGenPharma
Name
次回の収益日
2025-03-10
Name
最新のSEC提出書
Name
URGN's Discussions on Twitter

URGN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
URGN
Urogen Pharma Ltd
4.24 193.19M 82.71M -102.24M -76.57M -3.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Urogen Pharma Ltd Stock (URGN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-22 ダウングレード H.C. Wainwright Buy → Neutral
2025-04-16 開始されました Scotiabank Sector Outperform
2025-02-19 再開されました Ladenburg Thalmann Buy
2024-08-22 開始されました Guggenheim Buy
2023-02-08 ダウングレード Jefferies Buy → Hold
2022-04-27 開始されました Berenberg Buy
2020-04-16 繰り返されました H.C. Wainwright Buy
2020-04-13 繰り返されました H.C. Wainwright Buy
2020-01-09 開始されました National Securities Neutral
2019-05-30 開始されました JP Morgan Neutral
2019-05-29 開始されました Goldman Neutral
2019-01-29 開始されました H.C. Wainwright Buy
2018-11-08 再開されました Jefferies Buy
2018-04-04 アップグレード Raymond James Mkt Perform → Outperform
2018-01-02 開始されました Ladenburg Thalmann Buy
2017-11-15 繰り返されました Oppenheimer Outperform
2017-11-15 ダウングレード Raymond James Outperform → Mkt Perform
すべてを表示

Urogen Pharma Ltd (URGN) 最新ニュース

pulisher
May 31, 2025

Class Action Lawsuit Filed: UroGen Pharma Ltd. (URGN)Join by July 28, 2025Contact Levi & Korsinsky - ACCESS Newswire

May 31, 2025
pulisher
May 31, 2025

URGN CLASS ACTION NOTICE: UroGen Pharma Ltd. has been Sued - GlobeNewswire

May 31, 2025
pulisher
May 30, 2025

Levi & Korsinsky Investigates UroGen Pharma Ltd. (URGN) Over Possible Securities Fraud - ACCESS Newswire

May 30, 2025
pulisher
May 30, 2025

Pharma Co. Hid Cancer Study Method Problems, Investor Claims - Law360

May 30, 2025
pulisher
May 30, 2025

URGN ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of UroGen Pharma Ltd. Investors - Business Wire

May 30, 2025
pulisher
May 30, 2025

URGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

URGN Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against ... - Eagle-Tribune

May 30, 2025
pulisher
May 30, 2025

URGN FRAUD ALERT: UroGen Pharma Ltd. Investors are Alerted to Contact BFA Law about the Pending Securities Fraud Class Action - Newsfile

May 30, 2025
pulisher
May 30, 2025

URGN Investors Have Opportunity to Lead UroGen Pharma Ltd. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire

May 30, 2025
pulisher
May 30, 2025

UroGen Pharma Ltd. (URGN) Faces Securities Class Action - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

URGN BREAKING NEWS: UroGen Pharma Ltd. Stock Plummets 45% Triggering Shareholder Class Action – Contact BFA Law if You Lost Money (NASDAQ:URGN) - Business Wire

May 30, 2025
pulisher
May 30, 2025

UroGen Investor Sues After Cancer Therapy Setback, 45% Selloff - Bloomberg Law News

May 30, 2025
pulisher
May 30, 2025

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against UroGen Pharma Ltd. (URGN) - GlobeNewswire Inc.

May 30, 2025
pulisher
May 30, 2025

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

URGN Investors Have the Opportunity to Lead the UroGen Pharma Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - PR Newswire

May 30, 2025
pulisher
May 30, 2025

UroGen Pharma Ltd. (NASDAQ:URGN) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

May 30, 2025
pulisher
May 29, 2025

URGN Stockholder Alert: Robbins LLP Informs Investors of the UroGen Pharma Ltd. Class Action Lawsuit - Morningstar

May 29, 2025
pulisher
May 29, 2025

UroGen Pharma Ltd. Investors: Please contact the Portnoy - GlobeNewswire

May 29, 2025
pulisher
May 29, 2025

URGN INVESTOR ALERT: UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times

May 29, 2025
pulisher
May 29, 2025

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of UroGen - Business Wire

May 29, 2025
pulisher
May 29, 2025

Law Offices of Howard G. Smith Encourages UroGen Pharma Ltd. (URGN) Investors To Inquire About Securities Fraud Class Action - Business Wire

May 29, 2025
pulisher
May 29, 2025

UroGen Pharma Ltd. (URGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

May 29, 2025
pulisher
May 29, 2025

Did You Suffer Losses in UroGen Pharma Ltd. (URGN)? Contact Levi & Korsinsky About Securities Fraud Claims - ACCESS Newswire

May 29, 2025
pulisher
May 29, 2025

UroGen Pharma Ltd. (URGN) Shares Crash Again Amid FDA's ODAC Vote Against UGN-102, Company Facing Investor ScrutinyHagens Berman - PR Newswire

May 29, 2025
pulisher
May 28, 2025

Did UroGen Pharma Ltd. (URGN) Mislead Investors? Levi & Korsinsky Investigates - ACCESS Newswire

May 28, 2025
pulisher
May 28, 2025

Oppenheimer maintains Outperform on UroGen Pharma stock By Investing.com - Investing.com India

May 28, 2025
pulisher
May 27, 2025

Lost Money on UroGen Pharma Ltd. (URGN)? Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire

May 27, 2025
pulisher
May 27, 2025

UroGen Pharma to Present at TD Cowen: 6th Annual Oncology Innovation Summit: Insights for ASCO & EHA - New Castle News

May 27, 2025
pulisher
May 27, 2025

UroGen Pharma Ltd. (URGN) Shares Crash Again Amid FDA’s - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

UroGen Pharma Ltd. (NASDAQ:URGN) Stock Position Decreased by Millennium Management LLC - Defense World

May 27, 2025
pulisher
May 26, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against UroGen Pharma Ltd. (URGN) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

May 26, 2025
pulisher
May 26, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UroGen Pharma Ltd.URGN - PR Newswire

May 26, 2025
pulisher
May 26, 2025

Janus Henderson Group PLC Acquires New Stake in UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World

May 26, 2025
pulisher
May 26, 2025

Lazard Asset Management LLC Acquires New Holdings in UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World

May 26, 2025
pulisher
May 26, 2025

Q2 EPS Estimates for UroGen Pharma Raised by HC Wainwright - Defense World

May 26, 2025
pulisher
May 25, 2025

UroGen Pharma Stock Receives Downgrade As Analyst Cites FDA Panel Setback For Key Bladder Cancer Drug - Benzinga

May 25, 2025
pulisher
May 25, 2025

Guggenheim Has Lowered Expectations for UroGen Pharma (NASDAQ:URGN) Stock Price - Defense World

May 25, 2025
pulisher
May 25, 2025

The Goldman Sachs Group Cuts UroGen Pharma (NASDAQ:URGN) Price Target to $3.00 - Defense World

May 25, 2025
pulisher
May 24, 2025

Ongoing Investigation: UroGen Pharma Ltd. (URGN) May Have Misled ShareholdersLevi & Korsinsky Investigates - ACCESS Newswire

May 24, 2025
pulisher
May 24, 2025

Northern Trust Corp Purchases 23,345 Shares of UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World

May 24, 2025
pulisher
May 24, 2025

Kaplan Fox Reminds Investors of UroGen Pharma Ltd. (URGN) to an Investigation of Potential Securities Law Violations - FinancialContent

May 24, 2025
pulisher
May 23, 2025

Guggenheim's Michael Schmidt Lowers Price Target for UroGen Pharma (URGN) | URGN Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Kaplan Fox is Investigating Potential Securities Law Violations against UroGen Pharma Ltd. (URGN) - FinancialContent

May 23, 2025
pulisher
May 23, 2025

UroGen Pharma (URGN) Price Target Cut by Guggenheim | URGN Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

URGN ACTIVE INVESTIGATION: Lost Money on UroGen Pharma Ltd.? Contact Levi & Korsinsky Now - ACCESS Newswire

May 23, 2025
pulisher
May 23, 2025

UroGen crashes as FDA AdCom rebukes bladder cancer drug - MSN

May 23, 2025
pulisher
May 22, 2025

UroGen Pharma Shares Fall After HC Wainwright Downgrade - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Kaplan Fox Announces an Investigation Into UroGen Pharma Ltd. (URGN) for Potential Securities Law Violations - FinancialContent

May 22, 2025
pulisher
May 22, 2025

UroGen Pharma (URGN) Target Price Slashed by Goldman Sachs | URGN Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Goldman Sachs cuts UroGen Pharma target to $3 from $16 - Investing.com Australia

May 22, 2025
pulisher
May 22, 2025

UroGen tanks as FDA panel vote goes against UGN-102 - The Pharma Letter

May 22, 2025

Urogen Pharma Ltd (URGN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
大文字化:     |  ボリューム (24 時間):